These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Nakanishi K, Hagiwara A, Shibata M, Imaida K, Tatematsu M, Ito N. J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236 [Abstract] [Full Text] [Related]
6. The effects of catechol on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. La Voie EJ, Shigematsu A, Mu B, Rivenson A, Hoffmann D. Jpn J Cancer Res; 1985 Apr; 76(4):266-71. PubMed ID: 3924700 [Abstract] [Full Text] [Related]
7. Agglutination of bladder cells by concanavalin A during the early phase of treatment of rats with N-butyl-N-(4-hydroxybutyl)nitrosamine. Kakizoe T, Kawachi T, Sugimura T. Cancer Res; 1979 Sep; 39(9):3353-6. PubMed ID: 476666 [Abstract] [Full Text] [Related]
8. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Shirai T, Tagawa Y, Fukushima S, Imaida K, Ito N. Cancer Res; 1987 Dec 15; 47(24 Pt 1):6726-30. PubMed ID: 3677102 [Abstract] [Full Text] [Related]
10. Inhibition of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by alpha-difluoromethylornithine. Homma Y, Kakizoe T, Samma S, Oyasu R. Cancer Res; 1987 Dec 01; 47(23):6176-9. PubMed ID: 3119193 [Abstract] [Full Text] [Related]
11. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Tatematsu M, Lurie AG, Rippey RM, Conran PB, Arai M, Fukushima S, Ito N. Cancer Res; 1984 Jan 01; 44(1):278-84. PubMed ID: 6690039 [Abstract] [Full Text] [Related]
12. Effects of sex hormones on oncogenesis in rat urinary bladder by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Tanahashi NK, Suzawa N, Azuma C. Int J Clin Pharmacol Biopharm; 1977 Mar 01; 15(3):101-5. PubMed ID: 844928 [Abstract] [Full Text] [Related]
13. Cataracts in rats given a bladder carcinogen, N-butyl-N-(4-hydroxybutyl)-nitrosamine. Fujita J, Yoshida O, Fujita H, Mikuni I. Tokai J Exp Clin Med; 1983 Nov 01; 8(4):359-63. PubMed ID: 6679940 [Abstract] [Full Text] [Related]
14. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Hiasa Y, Kitahori Y, Konishi N, Shimoyama T, Miyashiro A. J Natl Cancer Inst; 1985 Jan 01; 74(1):235-9. PubMed ID: 3855482 [Abstract] [Full Text] [Related]
15. [The lithium carbonate promotion of urothelial tumors in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine]. Frolov AG, Pliss GB. Vopr Onkol; 1992 Jan 01; 38(11):1309-13. PubMed ID: 1343160 [Abstract] [Full Text] [Related]
16. [Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine]. Okajima E, Hiramatsu T, Okamoto M, Kihoin K, Ijuin M, Hirao Y, Ohara S, Babaya K, Kubota K, Samma S, Okamura K, Kaneko Y, Horii Y, Moriya A. Gan To Kagaku Ryoho; 1982 May 01; 9(5):836-42. PubMed ID: 7184430 [Abstract] [Full Text] [Related]
17. Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine. Ohtani M, Kakizoe T, Nishio Y, Sato S, Sugimura T, Fukushima S, Niijima T. Cancer Res; 1986 Apr 01; 46(4 Pt 2):2001-4. PubMed ID: 3948177 [Abstract] [Full Text] [Related]
18. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats. Oliveira PA, Colaço A, De la Cruz LF, Lopes P, Lopes C. J Exp Clin Cancer Res; 2006 Sep 01; 25(3):425-32. PubMed ID: 17167984 [Abstract] [Full Text] [Related]